Martha Altieri

2.3k total citations · 2 hit papers
10 papers, 1.9k citations indexed

About

Martha Altieri is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Martha Altieri has authored 10 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Genetics. Recurrent topics in Martha Altieri's work include Protein Degradation and Inhibitors (5 papers), Diabetes and associated disorders (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Martha Altieri is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Diabetes and associated disorders (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Martha Altieri collaborates with scholars based in United States, Japan and Germany. Martha Altieri's co-authors include Kanak Raina, James D. Winkler, Andrew P. Crew, Kevin Coleman, Jing Lü, Yimin Qian, Hanqing Dong, Craig M. Crews, Jing Wang and John Hines and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Martha Altieri

10 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

2015 849 citations Jing Lü, Yimin Qian et al. Chemistry & Biology profile →
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

2016 661 citations Kanak Raina, Jing Lü et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martha Altieri United States	7	1.5k	511	508	291	219	10	1.9k
Niranjan Yanamandra United States	18	441 0.3×	155 0.3×	265 0.5×	94 0.3×	122 0.6×	28	823
Lars Anders United States	7	1.1k 0.7×	129 0.3×	497 1.0×	73 0.3×	111 0.5×	12	1.5k
Daniel Dauch Germany	13	689 0.5×	85 0.2×	224 0.4×	43 0.1×	88 0.4×	20	1.0k
Jian‐Min Luo China	18	966 0.6×	71 0.1×	232 0.5×	105 0.4×	93 0.4×	44	1.3k
Sabrina Giavara Italy	4	1.1k 0.7×	208 0.4×	826 1.6×	237 0.8×	92 0.4×	5	1.4k
Arianna Sabò Italy	19	1.5k 1.0×	91 0.2×	430 0.8×	60 0.2×	269 1.2×	25	1.9k
Laurie Beitz United States	7	586 0.4×	75 0.1×	97 0.2×	83 0.3×	446 2.0×	9	1.0k
Mark Miglarese United States	12	689 0.5×	44 0.1×	375 0.7×	37 0.1×	68 0.3×	31	960
Debra M. Hunter United States	19	538 0.4×	49 0.1×	376 0.7×	51 0.2×	677 3.1×	31	1.3k
Nadine Mayotte Canada	21	852 0.6×	563 1.1×	186 0.4×	99 0.3×	269 1.2×	38	1.3k

Countries citing papers authored by Martha Altieri

Since Specialization

Citations

This map shows the geographic impact of Martha Altieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Altieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Altieri more than expected).

Fields of papers citing papers by Martha Altieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Altieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Altieri. The network helps show where Martha Altieri may publish in the future.

Co-authorship network of co-authors of Martha Altieri

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Altieri. A scholar is included among the top collaborators of Martha Altieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Altieri. Martha Altieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Winkler, Julia, Kanak Raina, Martha Altieri, et al.. (2016). PROTAC BET degraders are more broadly effective than BET inhibitors. European Journal of Cancer. 69. S10–S10. 3 indexed citations

2.

Raina, Kanak, Jing Lü, Yimin Qian, et al.. (2016). PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 113(26). 7124–7129. 661 indexed citations breakdown →

3.

Lü, Jing, Yimin Qian, Martha Altieri, et al.. (2015). Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 22(6). 755–763. 849 indexed citations breakdown →

4.

Lü, Jing, Yimin Qian, Kanak Raina, et al.. (2015). BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL. Blood. 126(23). 2050–2050. 3 indexed citations

5.

Coleman, Kevin, Jing Lü, Yimin Qian, et al.. (2015). BRD4 degraders produce long-lasting loss of BRD4 Ppotein and robust efficacy in Burkitt’s lymphoma cells.. Journal of Clinical Oncology. 33(15_suppl). 8557–8557. 1 indexed citations

6.

Verma, Sharad, Dhanapalan Nagarathnam, Lei Zhang, et al.. (2005). Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(8). 1973–1977. 18 indexed citations

7.

Li, Wen, F. Susan Wong, Jie Tang, et al.. (2000). In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes. The Journal of Experimental Medicine. 191(1). 97–104. 79 indexed citations

8.

Li, Wen, F. Susan Wong, Linda C. Burkly, et al.. (1998). Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.. Journal of Clinical Investigation. 102(5). 947–957. 51 indexed citations

9.

Zekzer, Dan, F. Susan Wong, Oran Ayalon, et al.. (1998). GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.. Journal of Clinical Investigation. 101(1). 68–73. 131 indexed citations

10.

Zekzer, Dan, F. Susan Wong, Wen Li, et al.. (1997). Inhibition of Diabetes by an Insulin-Reactive CD4 T-Cell Clone in the Nonobese Diabetic Mouse. Diabetes. 46(7). 1124–1132. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact